NYSE:ARDT Ardent Health Partners (ARDT) Stock Price, News & Analysis $12.48 -0.08 (-0.64%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$12.52 +0.04 (+0.28%) As of 04/25/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Ardent Health Partners Stock (NYSE:ARDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ardent Health Partners alerts:Sign Up Key Stats Today's Range$12.25▼$12.6650-Day Range$11.61▼$15.3152-Week Range$11.31▼$20.72Volume174,800 shsAverage Volume403,496 shsMarket Capitalization$1.78 billionP/E RatioN/ADividend YieldN/APrice Target$20.58Consensus RatingBuy Company OverviewArdent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Read More… Ardent Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreARDT MarketRank™: Ardent Health Partners scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingArdent Health Partners has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageArdent Health Partners has only been the subject of 4 research reports in the past 90 days.Read more about Ardent Health Partners' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth59.35% Earnings GrowthEarnings for Ardent Health Partners are expected to grow by 59.35% in the coming year, from $1.23 to $1.96 per share.Read more about Ardent Health Partners' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ARDT. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldArdent Health Partners does not currently pay a dividend.Dividend GrowthArdent Health Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ARDT. News and Social Media3.4 / 5News Sentiment1.07 News SentimentArdent Health Partners has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Ardent Health Partners this week, compared to 4 articles on an average week.Search Interest3 people have searched for ARDT on MarketBeat in the last 30 days. MarketBeat FollowsOnly 3 people have added Ardent Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Ardent Health Partners insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.70% of the stock of Ardent Health Partners is held by insiders.Read more about Ardent Health Partners' insider trading history. Receive ARDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ardent Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDT Stock News HeadlinesBoasting A 20% Return On Equity, Is Ardent Health Partners, Inc. (NYSE:ARDT) A Top Quality Stock?April 24 at 6:12 PM | uk.finance.yahoo.comArdent Health Announces First Quarter 2025 Results Conference Call and Webcast DateApril 24 at 5:22 AM | businesswire.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 26, 2025 | Porter & Company (Ad)Ardent Health Partners, LLC (NYSE:ARDT) Given Average Rating of "Buy" by BrokeragesApril 24 at 2:05 AM | americanbankingnews.comArdent Health price target lowered to $18 from $19 at MizuhoApril 10, 2025 | markets.businessinsider.comArdent Health initiated with a Buy at GuggenheimApril 10, 2025 | markets.businessinsider.comGuggenheim Initiates Coverage of Ardent Health Partners (ARDT) with Buy RecommendationApril 9, 2025 | msn.comArdent Health Appoints Robert DeMichiei to Board of DirectorsApril 3, 2025 | gurufocus.comSee More Headlines ARDT Stock Analysis - Frequently Asked Questions How have ARDT shares performed this year? Ardent Health Partners' stock was trading at $17.08 on January 1st, 2025. Since then, ARDT stock has decreased by 26.9% and is now trading at $12.48. View the best growth stocks for 2025 here. How were Ardent Health Partners' earnings last quarter? Ardent Health Partners, LLC (NYSE:ARDT) released its earnings results on Wednesday, February, 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm earned $1.61 billion during the quarter, compared to analysts' expectations of $1.48 billion. Read the conference call transcript. When did Ardent Health Partners IPO? Ardent Health Partners (ARDT) raised $192 million in an IPO on Thursday, July 18th 2024. The company issued 12,000,000 shares at a price of $16.00 per share. Who are Ardent Health Partners' major shareholders? Top institutional shareholders of Ardent Health Partners include Allspring Global Investments Holdings LLC (0.57%), Peregrine Capital Management LLC (0.23%), Rhumbline Advisers (0.02%) and TBH Global Asset Management LLC (0.01%). How do I buy shares of Ardent Health Partners? Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ardent Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML). Company Calendar Last Earnings2/26/2025Today4/25/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry General medical & surgical hospitals Sub-IndustryHealthcare Current SymbolNYSE:ARDT Previous SymbolNYSE:ARDT CIK1756655 WebN/A Phone(615) 296-3000FaxN/AEmployees24,200Year FoundedN/APrice Target and Rating Average Stock Price Target$20.58 High Stock Price Target$25.00 Low Stock Price Target$16.00 Potential Upside/Downside+65.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.78 Current Ratio1.91 Quick Ratio1.78 Sales & Book Value Annual Sales$5.97 billion Price / Sales0.30 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares142,750,000Free FloatN/AMarket Cap$1.78 billion OptionableOptionable BetaN/A 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSE:ARDT) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardent Health Partners, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardent Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.